The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.26.2.87

Twenty-one paranoid schizophrenics who were being treated in a therapeutic community were divided into groups with grandiose and nongrandiose symptomatology, based on ratings on the Inpatient Multidimensional Psychiatric Scale. The nine nongrandiose patients showed significantly greater improvement during hospitalization. A follow-up of five non-grandiose and nine grandiose patients one year after discharge revealed a trend toward greater improvement by the nongrandiose group. The authors feel that a patient's grandiosity creates a barrier that keeps the therapist and the members of the therapeutic community at a distance and makes him less accessible to therapeutic intervention. The field dependence of patients was also rated, but was of no prognostic significance.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.